80,047 GE HealthCare Technologies Inc. $GEHC Shares Sold by Kestra Advisory Services LLC

Kestra Advisory Services LLC decreased its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report) by 55.0% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 65,393 shares of the company’s stock after selling 80,047 shares during the period. Kestra Advisory Services LLC’s holdings in GE HealthCare Technologies were worth $4,275,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in GEHC. NBH Bank acquired a new stake in GE HealthCare Technologies during the 2nd quarter worth about $26,000. Provenance Wealth Advisors LLC increased its holdings in shares of GE HealthCare Technologies by 401.0% in the third quarter. Provenance Wealth Advisors LLC now owns 491 shares of the company’s stock valued at $32,000 after purchasing an additional 393 shares during the period. Fortitude Family Office LLC increased its holdings in shares of GE HealthCare Technologies by 249.1% in the third quarter. Fortitude Family Office LLC now owns 597 shares of the company’s stock valued at $39,000 after purchasing an additional 426 shares during the period. Aberdeen Wealth Management LLC purchased a new position in shares of GE HealthCare Technologies in the second quarter worth about $44,000. Finally, Physician Wealth Advisors Inc. raised its stake in shares of GE HealthCare Technologies by 74.1% in the third quarter. Physician Wealth Advisors Inc. now owns 719 shares of the company’s stock worth $47,000 after purchasing an additional 306 shares during the last quarter. Hedge funds and other institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Price Performance

GE HealthCare Technologies stock opened at $83.02 on Monday. The business’s 50-day moving average price is $70.55 and its 200 day moving average price is $70.11. The company has a quick ratio of 1.01, a current ratio of 1.30 and a debt-to-equity ratio of 0.86. The firm has a market cap of $37.54 billion, a price-to-earnings ratio of 17.51, a price-to-earnings-growth ratio of 2.09 and a beta of 0.64. GE HealthCare Technologies Inc. has a 52 week low of $58.75 and a 52 week high of $89.77.

GE HealthCare Technologies (NASDAQ:GEHC – Get Free Report) last announced its quarterly earnings results on Wednesday, October 28th. The company reported $1.34 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.20 by $0.14. GE HealthCare Technologies had a return on equity of 20.45% and a net margin of 9.96%. The company had revenue of $5.51 billion during the quarter, compared to the consensus estimate of $5.35 billion. During the same period in the previous year, the company posted $1.07 earnings per share. GE HealthCare Technologies’s revenue for the quarter was up 7.2% on a year-over-year basis. As a group, sell-side analysts anticipate that GE HealthCare Technologies Inc. will post 5.02 earnings per share for the current year.

GE HealthCare Technologies Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, November 13th. Stockholders of record on Friday, October 23rd were paid a dividend of $0.04 per share. This represents a $0.16 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date of this dividend was Friday, October 23rd. This is a positive change from GE HealthCare Technologies’s previous quarterly dividend of $0.0350. GE HealthCare Technologies’s dividend payout ratio is 3.38%.

Analysts Set New Price Targets

A number of equities research analysts recently commented on GEHC shares. Zacks Research raised GE HealthCare Technologies from a “strong sell” rating to a “hold” rating in a report on Tuesday, August 11th. Piper Sandler reiterated a “buy” rating on shares of GE HealthCare Technologies in a report on Wednesday, July 29th. BTIG Research increased their price target on shares of GE HealthCare Technologies from $75.00 to $83.00 and gave the stock a “buy” rating in a report on Wednesday, October 28th. Wall Street Zen raised shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating in a research report on Saturday, October 31st. Finally, Oppenheimer restated an “outperform” rating on shares of GE HealthCare Technologies in a research note on Thursday, July 30th. Twelve investment analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $82.17.

Read Our Latest Research Report on GE HealthCare Technologies

About GE HealthCare Technologies

(Free Report)

GE HealthCare Technologies Inc. is a global medical technology company that develops and provides equipment, software and services for healthcare providers. Its offerings support medical imaging, diagnosis, patient monitoring and treatment across a range of clinical settings. The company’s products include magnetic resonance imaging, computed tomography, molecular imaging and ultrasound systems, as well as patient monitoring and care solutions. Its Pharmaceutical Diagnostics business supplies contrast agents and radiopharmaceuticals used in medical imaging.

Featured Stories

Want to see what other hedge funds are holding GEHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report).

Institutional Ownership by Quarter for GE HealthCare Technologies (NASDAQ:GEHC)

Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.